AI Article Synopsis

  • - The study analyzed 3,556 patients referred for haematuria investigation, finding a 10% incidence of urinary tract cancer, with higher rates in those with visible haematuria (VH) compared to nonvisible (NVH) cases (13.8% vs 3.1%).
  • - Key risk factors for urinary tract cancer included older age, male gender, and smoking history; notably, a significant portion of bladder cancers found in NVH patients were high-risk.
  • - The findings suggest that all patients with VH should be investigated regardless of age, while NVH patients, who typically show lower cancer rates, may still have clinically significant cancers that could be missed if strict age thresholds for investigation are applied. *

Article Abstract

Unlabelled: There remains a lack of consensus among guideline relating to which patients require investigation for haematuria. We determined the incidence of urinary tract cancer in a prospective observational study of 3556 patients referred for investigation of haematuria across 40 hospitals between March 2016 and June 2017 (DETECT 1; ClinicalTrials.gov: NCT02676180) and the appropriateness of age at presentation in cases with visible (VH) and nonvisible (NVH) haematuria. The overall incidence of urinary tract cancer was 10.0% (bladder cancer 8.0%, renal parenchymal cancer 1.0%, upper tract transitional cell carcinoma 0.7%, and prostate cancer 0.3%). Patients with VH were more likely to have a diagnosis of urinary tract cancer compared with NVH patients (13.8% vs 3.1%). Older patients, male gender, and smoking history were independently associated with urinary tract cancer diagnosis. Of bladder cancers diagnosed following NVH, 59.4% were high-risk cancers, with 31.3% being muscle invasive. The incidence of cancer in VH patients <45 yr of age was 3.5% (n=7) and 1.0% (n=4) in NVH patients <60 yr old. Our results suggest that patients with VH should be investigated regardless of age. Although the risk of urinary tract cancer in NVH patients is low, clinically significant cancers are detected below the age threshold for referral for investigation.

Patient Summary: This study highlights the requirement to investigate all patients with visible blood in the urine and an age threshold of ≥60 yr, as recommended in some guidelines, as the investigation of nonvisible blood in the urine will miss a significant number of urinary tract cancers. Patient preference is important, and evidence that patients are willing to submit to investigation should be considered in reaching a consensus recommendation for the investigation of haematuria. International consensus to guide that patients will benefit from investigation should be developed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2018.03.008DOI Listing

Publication Analysis

Top Keywords

urinary tract
16
tract cancer
16
prospective observational
8
observational study
8
study 3556
8
3556 patients
8
investigation haematuria
8
incidence urinary
8
cancer
8
patients
7

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!